23 May 2013
Keywords: astrazeneca, hit, news, approval, delay, lipid-lowerer, crestor
Article | 06 May 2002
AstraZeneca shares fell more than 5% to L33.40 on the day of itsfirst-quarter results meeting (see also page 3) as news of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 May 2002
27 May 2002
© 2013 thepharmaletter.com